Adele M Gulfo

Chief of Commercial Development - Roivant Sciences Ltd.

Prior to joining Roivant in 2018, Gulfo served as EVP and head of global commercial development for Mylan N.V. She previously held leadership positions at AstraZeneca Pharmaceuticals, Parke-Davis, Pfizer Inc., SpectraTech Inc., and Fischer Scientific. She has been awarded five U.S. patents for innovative packaging designed to help patients adhere to their medicines. She currently serves on the board of Bemis Company Inc.

Relationships Interlocks Giving Data

Board Memberships

EnPro Industries Provides engineered industrial products. Revenues are $2 billion.

• Board Member ('19→?)

Bemis Supplier of packaging used by food, consumer products, and health care companies. Revenues are $4 billion.

• Board Member ('15→?)

Donations

Pfizer Inc. PAC

• 48 contributions · 10,000 USD (Jan 31 '10→Dec 31 '13)

Federal Election Campaign Contributions

Pfizer Inc. PAC

• 48 contributions · 9,984 USD (Jan 31 '10→Dec 31 '13)

Mylan Inc. Pharmaceutical company

• 20 contributions · 4,300 USD (Mar 31 '15→Nov 28 '16)

Brian P Bilbray US Representative from California

• 1 contribution · 2,500 USD (Sep 18 '12)